---
description: Simple summary as per UCLH JRO interventional studies protocol
---

# JRO study summary

<table data-header-hidden><thead><tr><th width="300.1796875" valign="top"></th><th></th></tr></thead><tbody><tr><td valign="top">IRAS Number</td><td> </td></tr><tr><td valign="top">REC Reference No.</td><td> </td></tr><tr><td valign="top">Sponsor Reference No.</td><td> </td></tr><tr><td valign="top">Other research reference number(s) (if applicable)</td><td>(e.g. UCL Data Protection number)</td></tr><tr><td valign="top">Full (Scientific) title</td><td><strong>INGLES</strong>-Guidelines<br><br><strong>I</strong>nâ€‘situ <strong>N</strong>udges for <strong>G</strong>uidelines, <strong>L</strong>ocal resistance, <strong>E</strong>stimated <strong>S</strong>usceptibility</td></tr><tr><td valign="top">Health condition(s) or problem(s) studied</td><td>Antibiotic guideline compliance via electronic point-of-care alerts</td></tr><tr><td valign="top">Study Type i.e. Cohort etc</td><td></td></tr><tr><td valign="top">Aim(s):</td><td>Improve guideline compliance for antibiotic prescribing through targeted notifications at the point of care  </td></tr><tr><td valign="top">Objectives:</td><td><em>Primary</em> <br>To improve compliance with hospital antibiotic prescribing guidelines<br><br><em>Secondary</em><br>To reduce prescribing of 'watch' or 'reserve' antibiotics<br>To increase the use of oral antibiotics<br>To reduce complications associated with antibiotic prescribing (resistance, diarrhoea etc.)</td></tr><tr><td valign="top">Type of trial:</td><td>Single centre, parallel assignment, randomised controlled trial without masking</td></tr><tr><td valign="top">Trial design and methods:</td><td>PICO</td></tr><tr><td valign="top">Trial duration per participant:</td><td>7 days</td></tr><tr><td valign="top"><p>Key Study milestones</p><p> </p></td><td><ul><li>Approved peer review of protocol</li><li>JRO submission and sponsorship</li><li>HRA and NHS REC approval</li><li>1st patient recruited<br></li></ul></td></tr><tr><td valign="top">Estimated total trial duration:</td><td></td></tr><tr><td valign="top">Planned trial sites:</td><td>University College Hospital London</td></tr><tr><td valign="top">Total number of participants planned:</td><td></td></tr><tr><td valign="top">Main inclusion/exclusion criteria:</td><td>Patients presenting to UCLH with a new community acquired urinary tract infection</td></tr><tr><td valign="top">Statistical methodology and analysis:</td><td>Briefly describe the statistical methodology to be used in the trial.</td></tr><tr><td valign="top"><strong>FUNDING &#x26; OTHER</strong></td><td>-</td></tr><tr><td valign="top">Funding</td><td>UCLH Biomedical Research Centre</td></tr><tr><td valign="top">Other support</td><td>Insert details of the non-financial support given, and the names &#x26; contact details of all organisation providing the non-financial support.</td></tr><tr><td valign="top"><strong>STORAGE of SAMPLES / DATA</strong> <br>(if applicable)</td><td>-</td></tr><tr><td valign="top">Human tissue samples</td><td>Insert name and contact details for where samples will be transferred and/or analysed if external to the organisation.</td></tr><tr><td valign="top">Data collected / Storage</td><td>Insert name and contact details were the data will be transferred to for storage and analysis if external to the research group and institution.</td></tr><tr><td valign="top"><p><strong>KEY STUDY CONTACTS</strong></p><p>Full contact details including phone, email and fax numbers</p></td><td>-</td></tr><tr><td valign="top">Committees</td><td>Name(s) of committees, full contact details including, phone and email. E.g. study steering groups. For each committee/group, the protocol should state their roles and responsibilities and degree of independence from the Sponsor and Investigators.</td></tr><tr><td valign="top">Sub-contractors</td><td> </td></tr><tr><td valign="top">Other relevant study personnel</td><td>(E.g. Data Custodian and Data Processors)</td></tr></tbody></table>



{% hint style="info" %}
See [UCL/UCLH Interventional studies protocol template](https://www.ucl.ac.uk/joint-research-office/sites/joint_research_office/files/jro_interventional_protocol_template.docx)
{% endhint %}
